{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:56:54Z","timestamp":1767866214697,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s13318-021-00712-1","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T07:02:52Z","timestamp":1629788572000},"page":"771-778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography\u2013Tandem Mass Spectrometry"],"prefix":"10.1007","volume":"46","author":[{"given":"Courtney","family":"Gearlds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Brooke","family":"Bouldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariah","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-334X","authenticated-orcid":false,"given":"Brooks B.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"712_CR1","unstructured":"\u2018Bath Salts\u2019 linked to nearly 23,000 Emergency room visits in 2011. National Association of Boards of Pharmacy. Published August 2, 2016. https:\/\/nabp.pharmacy\/news\/news-releases\/bath-salts-linked-to-nearly-23000-emergency-room-visits-in-2011\/. Accessed 20 May 2020."},{"issue":"4","key":"712_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology. 2013;38(4):552\u201362. https:\/\/doi.org\/10.1038\/npp.2012.204.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"712_CR3","first-page":"571","volume":"37","author":"JA Gershman","year":"2012","unstructured":"Gershman JA, Fass AD. Synthetic cathinones (\u2018bath salts\u2019): legal and health care challenges. P T. 2012;37(10):571\u201395.","journal-title":"P T"},{"issue":"1","key":"712_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","volume":"13","author":"L Karila","year":"2015","unstructured":"Karila L, Megarbane B, Cottencin O, Lejoyeux M. Synthetic cathinones: a new public health problem. Curr Neuropharmacol. 2015;13(1):12\u201320. https:\/\/doi.org\/10.2174\/1570159X13666141210224137.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"712_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","volume":"8","author":"JM Prosser","year":"2012","unstructured":"Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol. 2012;8(1):33\u201342. https:\/\/doi.org\/10.1007\/s13181-011-0193-z.","journal-title":"J Med Toxicol"},{"issue":"1","key":"712_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-019-00020-2","volume":"36","author":"SA Allen","year":"2019","unstructured":"Allen SA, Tran LH, Oakes HV, Brown RW, Pond BB. Dopaminergic effects of major bath salt constituents 3,4-methylenedioxypyrovalerone (MDPV), mephedrone, and methylone are enhanced following co-exposure. Neurotox Res. 2019;36(1):132\u201343. https:\/\/doi.org\/10.1007\/s12640-019-00020-2.","journal-title":"Neurotox Res"},{"issue":"3","key":"712_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00213-013-2967-2","volume":"227","author":"K Cameron","year":"2013","unstructured":"Cameron K, Kolanos R, Vekariya R, De Felice L, Glennon RA. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of \u201cbath salts,\u201d produce opposite effects at the human dopamine transporter. Psychopharmacology (Berl). 2013;227(3):493-9. https:\/\/doi.org\/10.1007\/s00213-013-2967-2. Erratum in: Psychopharmacology (Berl). 2013;227(3):447. Verkariya, Rakesh [corrected to Vekariya, Rakesh].","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"712_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/dta.1369","volume":"5","author":"AJ Pedersen","year":"2013","unstructured":"Pedersen AJ, Reitzel LA, Johansen SS, Linnet K. In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal. 2013;5(6):430\u20138.","journal-title":"Drug Test Anal"},{"issue":"6","key":"712_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1124\/dmd.112.050880","volume":"41","author":"AJ Pedersen","year":"2013","unstructured":"Pedersen AJ, Petersen TH, Linnet K. In vitro metabolism and pharmacokinetic studies on methylone. Drug Metab Dispos. 2013;41(6):1247\u201355.","journal-title":"Drug Metab Dispos"},{"key":"712_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/jms.1859","volume":"45","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Du P, Schuster F, Maurer HH. Studies on the metabolism of the \u03b1-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC\u2013MS and LC\u2013high-resolution MS and its detectability in urine by GC\u2013MS. J Mass Spectrom. 2010;45:1426\u201342.","journal-title":"J Mass Spectrom"},{"key":"712_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ntt.2017.08.001","volume":"63","author":"LG Strange","year":"2017","unstructured":"Strange LG, Kochelek K, Keasling R, Brown SD, Pond BB. The pharmacokinetic profile of synthetic cathinones in a pregnancy model. Neurotoxicol Teratol. 2017;63:9\u201313.","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"712_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bcpt.12253","volume":"115","author":"L Karlsson","year":"2014","unstructured":"Karlsson L, Andersson M, Kronstrand R, Kugelberg FC. Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Basic Clin Pharmacol Toxicol. 2014;115(5):411\u20136. https:\/\/doi.org\/10.1111\/bcpt.12253.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"712_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1471-4159.2011.07632.x","volume":"120","author":"M Angoa-P\u00e9rez","year":"2012","unstructured":"Angoa-P\u00e9rez M, Kane MJ, Francescutti DM, Sykes KE, Shah MM, Mohammed AM, Thomas DM, Kuhn DM. Mephedrone, an abused psychoactive component of \u2018bath salts\u2019 and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem. 2012;120(6):1097\u2013107. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07632.x.","journal-title":"J Neurochem"},{"issue":"9","key":"712_CR14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/jat\/bkw074","volume":"40","author":"JR Peters","year":"2016","unstructured":"Peters JR, Keasling R, Brown SD, Pond BB. Quantification of synthetic cathinones in rat brain using HILIC-ESI-MS\/MS. J Anal Toxicol. 2016;40(9):718\u201325. https:\/\/doi.org\/10.1093\/jat\/bkw074.","journal-title":"J Anal Toxicol"},{"issue":"3","key":"712_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/npp.2016.213","volume":"42","author":"JS Elmore","year":"2017","unstructured":"Elmore JS, Dillon-Carter O, Partilla JS, Ellefsen KN, Concheiro M, Suzuki M, Rice KC, Huestis MA, Baumann MH. Pharmacokinetic profiles and pharmacodynamic effects for methylone and its metabolites in rats. Neuropsychopharmacology. 2017;42(3):649\u201360. https:\/\/doi.org\/10.1038\/npp.2016.213.","journal-title":"Neuropsychopharmacology"},{"key":"712_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fpsyt.2017.00306","volume":"8","author":"K \u0160\u00edchov\u00e1","year":"2018","unstructured":"\u0160\u00edchov\u00e1 K, Pinterov\u00e1 N, \u017didkov\u00e1 M, Horsley RR, Lhotkov\u00e1 E, \u0160tefkov\u00e1 K, Vejmola C, Uttl L, Bal\u00edkov\u00e1 M, Kucha\u0159 M, P\u00e1len\u00ed\u010dek T. Mephedrone (4-methylmethcathinone): acute behavioral effects, hyperthermic, and pharmacokinetic profile in rats. Front Psychiatry. 2018;8:306. https:\/\/doi.org\/10.3389\/fpsyt.2017.00306.","journal-title":"Front Psychiatry"},{"key":"712_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.drugalcdep.2017.07.011","volume":"179","author":"MD Hambuchen","year":"2017","unstructured":"Hambuchen MD, Hendrickson HP, Gunnell MG, McClenahan SJ, Ewing LE, Gibson DM, Berquist MD, Owens SM. The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats. Drug Alcohol Depend. 2017;179:347\u201354. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.07.011.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"712_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00213-018-4962-0","volume":"236","author":"N Benturquia","year":"2019","unstructured":"Benturquia N, Chevillard L, Poir\u00e9 C, Roussel O, Cohier C, Decl\u00e8ves X, Laplanche J, Etheve-Quelquejeu M, Chen H, M\u00e9garbane B. Is the 3,4-methylendioxypyrovalerone\/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect\/concentration relationships. Psychopharmacology. 2019;236(3):891\u2013901. https:\/\/doi.org\/10.1007\/s00213-018-4962-0.","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-021-00712-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T09:34:21Z","timestamp":1637141661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-021-00712-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1007\/s13318-021-00712-1","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"8 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by the Research Development Committee at East Tennessee State University and the Department of Pharmaceutical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Courtney Gearlds, Jessica Brooke Bouldin, Mariah McKinney, Shannon Schreiner, Stacy D. Brown, and Brooks B. Pond have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Experiments and procedures with the animals were performed following the regulations set forth by the NIH Guide for the Care and Use of Laboratory Animals. The protocols followed were approved by the University Committee on Animal Care (UCAC) at East Tennessee State University (Protocol number: 190505).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Data collection (CG, JBB, MM, and SS), Data analysis (SDB), funding, experimental design, data collection and analysis (BBP).","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}